If you’re having problems viewing this email, read the web version
My Meds & Me
Are you ready to change your approach to adverse event (AE) data collection to meet the challenges of the market whilst saving effort and cost by up to 60%?
 
The pharmacovigilance environment is changing and there are growing pressures; increasing case volumes across the product lifecycle, and increasing emphasis on proactive assessment of benefit-risk of product portfolios. Using the web-based Reportum® adverse event data capture solution will enable you to have rapid access to more complete safety data to meet these challenges directly.
Video
 
See how the Reportum® solution could work for you
 
Watch video
Are your paper-based processes able to withstand the greater demand for faster, more complete AE data?
AE case data is collected from a diverse number of sources, both spontaneous and solicited, via processes rooted in paper based methodologies, designed prior to the digital age in which we now operate. In addition these cases often require significant follow-up to ensure all data required for regulator and internal requirements are collected. This complexity is further increased when local affiliates are actively involved in the safety data collection process, meaning individuals from very different backgrounds, such as Sales Representatives, Medical Science Liaison personnel, office based affiliate staff and call centres are required to record, translate and transmit AEs to central pharmacovigilance, followed by cycles of additional questions and data clarification. Does this sound familiar?
Would you like to increase data quality and completeness at first interaction?
Reduce manual effort and associated errors?
Using the latest innovative technology, the web-based Reportum® adverse event and product quality capture solution delivers rapid access to complete and standardised AE data, enabling accelerated knowledge and understanding of any potential emerging safety or quality issues.
Implementing the Reportum® solution can reduce operational effort (and cost) by 60%+ versus current practices. Are you ready to see how the Reportum® solution works, and how it could bring value?
Video
 
Find out more from the
MyMeds&Me team
 
Contact us
Blog
Interested in learning more about how this fits in the modernization of pharmacovigilance?
Check out Andrew Rut’s latest blog as he discusses how technology is the final catalyst to transformation of drug safety.
 
Join the discussion
© MyMeds&Me Ltd
[email protected] | Unsubscribe
MyMeds&Me
5A Noel St
London
W1F 8GE
Follow us
Twitter LinkedIn